評(píng)論
打印
According to Gizmodo.com, "Earlier this July,
據(jù)美國(guó)知名科技博客Gizmodo報(bào)道：“今年七月早些時(shí)候，
the pharmaceutical company Pfizer announced price jumps for many of its brand name drugs,
美國(guó)的輝瑞制藥公司宣布大幅上調(diào)其多個(gè)品牌藥物的價(jià)格，
including the smoking cessation aid Chantix and the erectile dysfunction drug Viagra."
其中包括戒煙藥伐尼克蘭和勃起功能障礙藥物萬(wàn)艾可。”
Quickly after this announcement, they went back on their word
聲明發(fā)布后不久，
after President Donald Trump criticized them for their business decision on Twitter.
唐納德·特朗普總統(tǒng)就在推特上批評(píng)了輝瑞制藥的經(jīng)營(yíng)決策。之后，輝瑞制藥就食言了。
He even spoke to the company's CEO, Ian Read, directly.
他更是直接跟該制藥公司CEO晏·瑞德進(jìn)行了談話。
Gizmodo explained, "Trump has long pledged to tackle drug prices...
Gizmodo解釋道：“唐納德·特朗普長(zhǎng)久以來(lái)一直承諾要處理高藥價(jià)的問題，
he and his administration have still sworn to finally knock Big Pharma down a peg
特朗普和他的政權(quán)仍舊宣誓要打倒大型制藥公司，
and pop the ballooning costs of life-saving medications."
并且減少不斷高漲的救命藥的花費(fèi)。”
譯文屬可可原創(chuàng)，僅供學(xué)習(xí)交流使用，未經(jīng)許可請(qǐng)勿轉(zhuǎn)載。
